Last Updated: August 9, 2026

Patent: 8,684,969

✉ Email this page to a colleague

Summary for Patent: 8,684,969

Title:	Injection device with torsion spring and rotatable display
Abstract:	The present invention relates to an injection device comprising a torsion spring operatively connected to a dose setting member being adapted to set a dose to be ejected from the injection device. A rotatably mounted display member adapted to display the dose to be ejected in accordance with a setting of the dose setting member is also provided. The rotatably mounted display member is adapted to be rotated over an angle corresponding to at least one revolution of the display member. The display member may be implemented as a dose indicator barrel having numerals arranged along a helical path on an outer surface thereof, or alternatively, as a counting device having two or more display wheels having numerals arranged on an outer surface thereof.
Inventor(s):	Moller; Claus Schmidt (Fredensborg, DK), Markussen; Tom Hede (Bagsvaerd, DK), Enggaard; Christian Peter (Vejby, DK)
Assignee:	Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:	13/626,541
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,684,969
Patent Claims:	see list of patent claims

Details for Patent 8,684,969

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	LEVEMIR	insulin detemir	Injection	021536	June 16, 2005	8,684,969	2032-09-25
Novo Nordisk Inc.	LEVEMIR	insulin detemir	Injection	021536	October 31, 2013	8,684,969	2032-09-25
Novo Nordisk Inc.	NOVOLOG MIX 50/50	insulin aspart protamine and insulin aspart	Injectable Suspension	021810	August 26, 2008	8,684,969	2032-09-25
Seqirus Inc.	FLUAD	influenza vaccine, adjuvanted	Injection	125510	November 24, 2015	8,684,969	2032-09-25
Seqirus Inc.	FLUAD,FLUAD QUADRIVALENT	influenza vaccine, adjuvanted	Injection	125510	February 21, 2020	8,684,969	2032-09-25
Novo Nordisk Inc.	RYZODEG 70/30	insulin degludec and insulin aspart	Injection	203313	September 25, 2015	8,684,969	2032-09-25
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 8,684,969

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
South Africa	200703706	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2006045528	⤷ Start Trial
United States of America	10471214	⤷ Start Trial
United States of America	11446443	⤷ Start Trial
United States of America	2009054839	⤷ Start Trial
United States of America	2013035641	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.